Donald Trump, Medicare and coveragefor Lilly
Digest more
Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for their weight management indications for people with obesity, President Trump announced on Thursday.
23mon MSN
Ozempic Is About to Go on Sale
Even after Trump’s new deal, obesity drugs are still too expensive.
President Donald Trump announced that his administration has finally struck a deal with Novo Nordisk and Eli Lilly to reduce the cost of their GLP-1 weight loss drugs, Wegovy and Zepbound. Currently,
Everyday Health on MSN
White House Slashes GLP-1 Costs, Permits Medicare Coverage for Obesity
A deal with drugmakers also means that Medicare would cover obesity drugs for the first time. But certain limitations persist.
The agreement, announced by the White House, potentially unlocks a major new market for the mega-blockbuster drugs.